中文
 
苏州方舟基因药业有限公司
 
Welcome to Biopharmagen Corp., Fangzhou Suzhou.
 
 
    Prospective Bio-products(Phase I) Developed by Biopharmagen Corp.


  • Biopharmagen. Corp. is a leading high-tech gene-engineering drug development company in China, founded by a group of oversea Chinese scholars in 1994.

  • We have constructed 11000 m2 of R & D center and production lines in 2010.

  • The founder received “ Outstanding Entrepreneur Award” of one hundred Chinese oversea professionals of China in September, 2005.

  • In 2004, Biopharmaceutical R&D Center was jointly established by Chinese Academy of Medical Sciences, Peking Union Medical College and Biopharmagen. Corp., to strengthen research and recruit graduate students.
苏州方舟基因药业有限公司
  苏州方舟基因药业有限公司
  • In 2000, The National Post-Doctoral Research Station was established, and approved by the China Ministry of Human Resource Affairs.

  • The second generation of new rhG-CSF  was developed and selected as a priority project of “National 863 Program” industrialization projects.

  • We have received GMP of G-CSF (first generation) production line certified by CFDA in December, 1999.

  • In November 1999,rhG-CSF was broadcasted in CCTV “Scientific Expo” program: "the representative of the gene-engineering drugs – rhG-CSF is an outstanding representative in treatment of cancers."

  • Recombinant human granulocyte colony stimulating factor (rhG-CSF), the first product was developed independently by Biopharmagen. Corp. and identified as “National New Product” by National Ministry of Economic Relations and Trade in 1997.
                               
 
   
   
Biopharmagen Corp., Fangzhou Suzhou.          Tel:0512-62831269          Email:Suzhou@Biopharmagen.com